$179 M

PPHM Mkt cap, 22-Dec-2017

$12.6 M

Avid Bioservices Revenue Q1, 2019
Avid Bioservices Gross profit (Q1, 2019)1.2 M
Avid Bioservices Gross profit margin (Q1, 2019), %9.5%
Avid Bioservices Net income (Q1, 2019)-2 M
Avid Bioservices EBIT (Q1, 2019)-2 M
Avid Bioservices Cash, 31-Jul-201837.5 M

Avid Bioservices Revenue Breakdown

Embed Graph

Avid Bioservices revenue breakdown by business segment: 99.3% from Contract manufacturing services and 0.7% from Other

Avid Bioservices Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2018

Revenue

22.4 m26.8 m44.7 m53.6 m

Revenue growth, %

20%67%

Cost of goods sold

56.5 m

Gross profit

(2.9 m)

Gross profit Margin, %

(5%)

R&D expense

59.5 m

General and administrative expense

18.6 m16.5 m

Operating expense total

78.1 m17.7 m

EBIT

(35.7 m)(50.5 m)(56.4 m)(20.6 m)

EBIT margin, %

(159%)(189%)(126%)(38%)

Interest income

102 k

Net Income

(35.4 m)(50.4 m)(55.7 m)(21.8 m)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

7.4 m3.9 m5.5 m6.3 m5.7 m9.7 m9.5 m6.7 m5.6 m23.4 m10.7 m12.8 m46.7 m12.6 m

Cost of goods sold

16.2 m47.6 m11.4 m

Gross profit

(3.5 m)(963 k)1.2 m

Gross profit Margin, %

(27%)(2%)9%

R&D expense

7 m6.6 m10.2 m10 m11.3 m13.9 m14.2 m15.2 m8.6 m7 m6 m3.6 m3.7 m

General and administrative expense

4 m4.6 m4.9 m4.3 m4.3 m4.9 m4.4 m4.5 m5.1 m5 m4.6 m4.2 m3.9 m12.3 m3.2 m

Operating expense total

15.2 m13.6 m18.7 m18.4 m18.7 m23.4 m23.3 m23.6 m16.7 m27.4 m18.5 m28.3 m9.2 m13.5 m3.2 m

EBIT

(7.8 m)(9.7 m)(13.2 m)(12.1 m)(13 m)(13.8 m)(13.8 m)(16.9 m)(11.1 m)(4.1 m)(7.8 m)(1.2 m)(12.6 m)(14.5 m)(2 m)

EBIT margin, %

(106%)(251%)(240%)(193%)(229%)(142%)(145%)(251%)(198%)(17%)(73%)(99%)(31%)(16%)

Interest income

14 k83 k73 k

Net Income

(7.8 m)(9.7 m)(13.1 m)(12.1 m)(13 m)(13.7 m)(13.2 m)(16.8 m)(11.1 m)(4.1 m)(7.8 m)(1.2 m)(12.6 m)(24.8 m)(2 m)

Avid Bioservices Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

77.5 m68 m61.4 m42.3 m

Inventories

5.5 m7.4 m16.2 m33.1 m16.1 m

Current Assets

85.8 m80.5 m81.8 m67.8 m

PP&E

2.4 m15.1 m24.3 m26.5 m

Total Assets

90.5 m97.5 m109 m95.8 m

Accounts Payable

2.4 m10.4 m8.4 m5.8 m1.9 m

Current Liabilities

22.2 m37.3 m57.6 m37.9 m

Additional Paid-in Capital

470.8 m512.5 m559.1 m614.8 m

Retained Earnings

(403.3 m)(453.6 m)(509.3 m)(559.1 m)

Total Equity

67.7 m59 m50.1 m55.7 m

Financial Leverage

1.3 x1.7 x2.2 x1.7 x

Quarterly

USDQ2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

44.4 m63.2 m55.2 m59 m72 m67.5 m44.2 m49.1 m41.5 m37.3 m27.7 m17.9 m37.5 m

Inventories

4 m5.2 m6.1 m10.5 m12.6 m15.2 m25.3 m25.9 m33.8 m24.2 m16.5 m14.2 m9.2 m

Current Assets

51.3 m72.2 m68.6 m72.3 m89.5 m93.6 m78.2 m82.8 m83 m70.8 m49 m41 m56.9 m

PP&E

2.3 m2.5 m9 m18.4 m21.8 m23.8 m24.3 m24 m24.1 m24.4 m27.1 m26.3 m26.3 m

Total Assets

55.1 m76.5 m79.1 m92 m112.7 m119.1 m105.6 m109.9 m111.3 m100.3 m78.6 m69.9 m84.7 m

Accounts Payable

2.4 m1.9 m6.8 m9.8 m6.9 m7.8 m9.1 m11.6 m7.7 m4 m2.7 m1.9 m3.1 m

Current Liabilities

18.8 m20.7 m28.2 m35.6 m42.5 m58.2 m63.3 m66.4 m70 m42.4 m33.6 m36.3 m25.7 m

Additional Paid-in Capital

418.8 m447.9 m491.1 m522.6 m549.5 m557.1 m561 m566.3 m571.9 m594.5 m594 m593.6 m615 m

Retained Earnings

(383.3 m)(393 m)(441.5 m)(467.3 m)(480.5 m)(497.4 m)(520.3 m)(524.4 m)(532.2 m)(538.5 m)(551.1 m)(562.1 m)(558.4 m)

Total Equity

35.6 m55.1 m49.8 m55.4 m69.2 m59.9 m40.9 m42.2 m40 m56 m42.9 m31.5 m56.7 m

Financial Leverage

1.5 x1.4 x1.6 x1.7 x1.6 x2 x2.6 x2.6 x2.8 x1.8 x1.8 x2.2 x1.5 x

Avid Bioservices Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(35.4 m)(50.4 m)(55.7 m)(28.2 m)(21.8 m)

Depreciation and Amortization

986 k1 m1.5 m2.5 m2.6 m

Inventories

(1.2 m)(1.8 m)(8.8 m)(16.9 m)17 m

Accounts Payable

(391 k)3.3 m(3.5 m)(3.3 m)(4 m)

Cash From Operating Activities

(28.3 m)(36 m)(39.6 m)(39.8 m)(26.8 m)

Cash From Investing Activities

(2.5 m)(8.4 m)(8.8 m)(3 m)(19 k)

Dividends Paid

(232 k)(3.4 m)(4.1 m)(4.3 m)(4.3 m)

Cash From Financing Activities

73.1 m35 m41.8 m28.2 m22.3 m

Interest Paid

6 k4 k

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018Q1, 2019

Net Income

(7.8 m)(9.7 m)(13.1 m)(25.2 m)(13 m)(13.7 m)(13.2 m)(16.8 m)(11.1 m)(4.1 m)(7.8 m)(24.8 m)(2 m)

Depreciation and Amortization

277 k542 k1.9 m642 k

Inventories

(468 k)151 k6.1 m10.5 m12.6 m15.2 m25.3 m25.9 m33.8 m18.9 m(910 k)

Accounts Payable

2.5 m484 k6.8 m9.8 m6.9 m7.8 m9.1 m11.6 m7.7 m(3.9 m)1.2 m

Cash From Operating Activities

(12.6 m)(24.2 m)(28.1 m)(7.4 m)

Cash From Investing Activities

(833 k)(1.5 m)(2.1 m)2.8 m

Dividends Paid

(771 k)(1.5 m)

Cash From Financing Activities

9.2 m12.6 m1.4 m(141 k)

Avid Bioservices Ratios

USDY, 2018

Financial Leverage

1.5 x
Report incorrect company information

Avid Bioservices Operating Metrics

FY, 2016

Phase 1/2 Trials Products

1
Report incorrect company information